IPN.AX - Stock quotes

Live Stock Quotes - Symbol Lookup

The symbol you provided : IPN.AX doesn't appear to be registered!

News Headlines for IPN.AX

IMPORTANT: Bing News RSS feed has moved!
table bgColorffffbb border1pxtdGo to thenbspa hrefhttpapi.bing.comrss.aspxSourceNewsampMarketen-USampVersion2.0 ampQueryIPN.AXnew RSS pageanbspand renew your subscription.tdtable

Monday's ETF with Unusual Volume:
The SPDR SP International Industrial Sector ETF AMEX is seeing unusually high volume in afternoon trading Monday with over 53000 shares traded versus three month average volume of about 25000. Shares of were off about 0.3 on the day.

Ipsen Falls Most in Six Months on Writedowns: Paris Mover
Ipsen SA shares tumbled the most in six months after the French drugmaker said it may take writedowns of as much as 180 million euros 237 million against 2011 earnings. The shares slid as much as 6.8 percent the biggest intraday drop ...

Hatchery fish to be euthanized for testing positive for
poses no threat to human health so catching handling and eating a fish with the virus cant hurt you according to the U.S. Fish and Wildlife Service. But once the disease is in a fish hatchery its tough to get rid of. Thats why when the Service ...

Ipsen Acknowledges Tanakan® Delisting in France
PARIS--BUSINESS WIRE-- Regulatory News Ipsen Paris Euronext - ADR IPSEY acknowledges the French governments decision to no longer reimburse Tanakan Tramisal and Ginkogink presently manufactured at the industrial site of Dreux France.

Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement Santhera Regains Worldwide Rights for Fipamezole
LIESTAL Switzerland PARIS Jan 24 2012 BUSINESS WIRE -- --Ipsen Retains a Call Option for Worldwide License to the Program under Certain Conditions Regulatory News Santhera Pharmaceuticals SIX SANN and Ipsen Paris Euronext ...

Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement
Santhera Pharmaceuticals SIXSANN and Ipsen Paris Euronext ADR IPSEY announced today that they had renegotiated their fipamezole licensing agreement. Santhera regains the worldwide rights to the development and commercialization of ...

Ipsen Acknowledges Tanakan(R) Delisting in France Tanakan(R) Remains ...
PARIS Jan 27 2012 BUSINESS WIRE -- --This New Wave of Delisting Concerns All Drugs with an Insufficient Therapeutic Value That Are Still Reimbursed in France Regulatory News Ipsen Paris Euronext - ADR IPSEY acknowledges the French ...

Ipsen Acknowledges Tanakan(R) Delisting in France
Ipsen quoteszigman398835 FR-0.18 acknowledges the French governments decision to no longer reimburse TanakanR TramisalR and GinkoginkR presently manufactured at the industrial site of Dreux France. This decision is linked to ...

Third Straight Week Drop for Online Poker Traffic
Eight of the top ten sites lost ground this week while two rose. One of the bigger surprises is that International Poker Network witnessed a 10 percent drop despite its Bad Beat Jackpot rising over 1 million US. Elsewhere the worlds largest ...

Ipsen's fourth quarter and full year 2011 sales and other significant developments
In 2011 Group drug sales grew by 5.7 year-on-year excluding foreign exchange impacts. Consolidated Group sales reached 1159.8 million for the full year 2011 up 5.4 year-on-year excluding foreign exchange impacts. Sales generated in the ...

Live Stock Quotes